Bosaya Injection
Product Images NDC 83257-029

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bosaya (NDC 83257-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

An instructional diagram showing a subcutaneous injection syringe labeled BOSAYA (Denosumab-kyqq) before and after usage. The illustration details components such as the plunger rod, finger grips, syringe label, syringe barrel, needle safety guard and spring, and gray needle cap before use. After use, the diagram shows the used plunger rod, syringe barrel, needle, needle safety spring, and the gray needle cap removed.*

FDA Label Image

Image-02 (Image 02)

Illustration labeled Figure B shows two hands demonstrating the use of a syringe injection device. One hand holds the syringe barrel, while the other hand pulls back the plunger, indicated by an upward blue arrow, suggesting the removal of the plunger or preparation for injection.*

FDA Label Image

Image-03 (Image 03)

An instructional illustration showing recommended subcutaneous injection sites on a human body. The left side highlights the thigh area with a marked injection site, while the right side shows the upper arm and lower abdomen with marked areas for injection.*

FDA Label Image

Image-04 (Image 04)

An instructional illustration demonstrating how to perform a subcutaneous injection using an auto-injector device labeled 'SNAP'. The image shows hands holding the device pressed against the skin, indicating the injection procedure.*

FDA Label Image

Image-05 (Image 05)

An instructional illustration labeled Figure E showing a hand holding a syringe administering a subcutaneous injection into the skin. The image demonstrates the injection technique for a subcutaneous dosage form.*

FDA Label Image

Image-06 (Image 06)

A line chart comparing patient hip fracture incidence percentages over a 36-month study period between Denosumab and placebo groups. The x-axis represents study months from 0 to 36, and the y-axis shows patient hip fracture incidence from 0% to 10%. Two lines display a lower incidence trend for Denosumab compared to placebo.*

FDA Label Image

Image-07 (Image 07)

Packaging label for Bosaya (denosumab-kyqq) Injection 60 mg/mL, a subcutaneous injectable drug by Biocon Biologics Inc. The label includes storage instructions to refrigerate at 2°C to 8°C and warnings against freezing. The carton indicates it contains one single-dose prefilled syringe, with details on inactive ingredients and manufacturer information from Biocon Biologics Inc., Cambridge, MA, USA, with product origin from India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.